| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $173K | — |
| SG&A Expense | $815K | — |
| Operating Income | -$987K | — |
| Interest Expense | $14K | — |
| Pre-tax Income | -$995K | — |
| Net Income | -$995K | — |
| EPS (Basic) | $1.00 | — |
| EPS (Diluted) | $1.00 | — |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17K | +110.5% |
| Current Assets | $37K | +367.0% |
| Total Assets | $37K | +367.0% |
| Current Liabilities | $1.2M | +678.7% |
| Total Liabilities | $1.2M | +678.7% |
| Stockholders' Equity | -$1.1M | -695.9% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$733K | — |
| Financing Cash Flow | $741K | — |